Private investors in Asia, including family offices operating in Hong Kong, are showing a growing appetite for advanced medical technologies such as brain-computer interfaces and surgical robotics, as healthcare deal activity picks up across the region amid China’s biotechnology boom. “Asia is ageing, so there’s a…

Read the full story at South China Morning Post →